cs1@thebrightdirecation.com

Dr. Wang Xiaodong

46 years old
Deputy Chief Physician of Pediatric Department of Neurology
Peking University
Dr. Xiaodong Wang graduated from Suzhou Medical College in 1984 and since her graduation Dr. Xiaodong has been working in the research, teaching and science of the clinical treatment of paediatric nervous system diseases. Later she studied in the medical school of Peking university where she achived her PHD.
Dr. Xiaodong is an expert in the treatment of new-born babies, HIE, Acute Disseminated Encephalomyelitis, Green Barry Syndrome, children's intracranial infectious diseases, Infantile Cerebral Palsy, Acute Haemoplegia in infancy and childhood, Infantile Epilepsy, Hyperactivity Syndrome as well as many other areas. Then in 2006 to 2008 Dr. Xiaodong attended University of Rochester Medical Center and started her post-doctor research under the direction of Professor Mark Nobel who is an internationally recognized and well respected neural stem cell expert. The focus of her study was the function of the neural stem cells in the oxidative damage and repair of the central nervous system and its molecular mechanism.
Dr. Xiaodong Wang is now researching the clinical treatment of stem cells' organizational repair and regeneration in the Armed Forces Neural Science Research Institute stem cells transplantation department. Dr. Xiaodong excels at the super early stage diagnosis and stem cells transplantation treatment of Infantile Cerebral Palsy, and the treatment of Paediatric Myelitis and Sequelae of injury of spinal cord. She focused her studies on the subject of the treatment of diabetes with stem cells transplantation, and made some great improvements in this field.
Research Papers by Dr. Xiaodong
1. Bone marrow-derived Mesenchymal stem cells and lateral hepatocyte differentiation. Chinese Clinical Rehabilitation 2006; 10(45): 121–124. 2. Dendritic cells for immune therapy of primary liver cancer and the potential of cross-cutting research on bone marrow stem cell differentiation. Modern Oncology. 2005; 4: 56–70. 3. VX2 number of living cells with rabbit liver cancer model of success rate and time into the relationship between tumor. Modern Oncology. 2005; 4: 25–28. 4. Mesenchymal stem cells modulate differentiation in hepatocytes in VX2 implanted rabbit liver cancer. Blood 2005; 106: 4303. 5. Pharmacokinetic and pharmacodynamic effects of Clonazepam in children with epilepsy treated with Valproate: a preliminary study. Ther Drug Monit 2002 Aug; 24(4): 532–6.
Published Research Papers
1、Ren J, Wang XD. Mesenchymal stem cell modulates differentiation into hepatocyte cell in VX2 implanted rabbit liver cancer. Blood. 2005, 106:4303 (SCI included)
2、Wang Li and Wang XD. Pharmacokinetic and pharmacodynamic effects of clonazepam in children with epilepsy treated with valproate: a preliminary study. Ther Drug Monit. 2002,24(4):532-6 (SCI included,IF: 3.127)
3、Xiaodong Wang. A Case of Cryptococcusis Accompanging Ascariesis of Biliary Tract. Joint Congress of ICNA and AOCNA, 2002
4、Xiaodong Wang, Li WAng.EFFECT OF CLONAZEPAM ON SODIUM VALPROATE BY USING QPEEG. INTERNATIONAL CONGRESS EPILEPSY A DEVELOPING WORLD 1996,BEIJING
5、Xiaodong Wang, Li Wang.INTERACTIONS OF OTHER ANTIEPTIC DRUGS WITH CLONAZEPAM AND RELATED MECHANISMS. 4TH INTERNATIONAL CONGRESS OF THERAPEUTIC DRUG MONITORING AND CLINICAL TOXICOLOGY 1995, VIENNA, AUSTRIA
6、Xiaodong Wang, Li Wang.THE STUDY OF ALUMINUM-INDUCED RATS OSTEOMALACIA. SIXTH INTERNATIONAL CONFERENCE ON THE COMBINEAL EFFECTS OF ENUIRONMENTAL FACTORS 1994,TOYAMA,JAPAN
7、Xiaodong Wang, Li Wang. PATHOLOGICAL STUDY OF ALUMINUM-INDUCED RATS TESTICLE TOXICITY EFFECT. SIXTH INTERNATIONAL CONFERENCE ON THE COMBINEAL EFFECTS OF ENUIRONMENTAL FACTORS 1994年TOYAMA,JAPAN
8、Xiaodong Wang, Jun Ren, Lijun Di. Mesenchymal Stem Cells Modulates Differentiation into Hepatocyte Cell in VX2 Implanted Rabbit Liver Cancer. 2005 American Scociety of Hematology.

About Us

The Stem Cell Department of General hospital of Chinese People’s Armed Police Forces is the first neural stem cell transplantation centre in China, which went through the World Health Organisation (WHO) clinical trial registration. The Hospital has also obtained the FDA clinical trial approval and had our laboratory certified with Good Manufacturing Procedures (GMP) certification of stem cell research and preparation. So far we have used stem cell therapy to treat 16,000+ patients from more than 30 countries.

Why choose us

Our department is the first nerve stem cell transplantation center in the country and abroad, which has passed through the WHO clinical registration test, received FDA approval of a clinical trial and was certified by the laboratory with the GMP standard of research. So far, we have already treated about 16,000+ patients from more than 30 countries with stem cell transplantation.

Contact us

Address: YongDing Road 69#, Haidian District, Beijing

Telephoe: +86 10 56259395

E-mail: cs1@thebrightdirection.com

Connect with us

Invalid Input

Invalid Input

Invalid Input